Sex disparities in medication changes after metformin initiation are associated with small, clinically non-relevant, sex differences in HbA1c levels during follow-up

Pharmacoepidemiol Drug Saf. 2024 May;33(5):e5802. doi: 10.1002/pds.5802.

Authors

Sieta T de Vries¹, Stijn de Vos², Monika P Oktora¹, Petra Denig¹

Affiliations

¹ Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
² Research Institute of Pharmacy, Unit of PharmacoTherapy, Epidemiology and Economics, University of Groningen, Groningen, The Netherlands.

PMID: 38680119
DOI: 10.1002/pds.5802

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Diabetes Mellitus, Type 2* / blood
Diabetes Mellitus, Type 2* / drug therapy
Female
Follow-Up Studies
Glycated Hemoglobin* / analysis
Humans
Hypoglycemic Agents* / administration & dosage
Hypoglycemic Agents* / therapeutic use
Male
Metformin* / administration & dosage
Middle Aged
Sex Factors

Substances

Metformin
Glycated Hemoglobin
Hypoglycemic Agents
hemoglobin A1c protein, human